Search results
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 12 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 7 hours agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 17 hours agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
...Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion... With Sanofi And Erases Doubts...
Benzinga via Yahoo Finance· 13 hours agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 9 hours agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 13 hours agoUnder the terms of the agreement, Sanofi will begin to book sales of Novavax’s COVID-19 vaccine...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 12 hours agoNovavax stock (NVAX) skyrocketed on Friday, gaining as much as 120% on the news French drug and vaccine giant Sanofi (SNY) would invest ...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 14 hours agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 18 hours agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
Novavax Stock Surges 140% on $1.4 Billion Deal With Sanofi
Barrons.com· 13 hours agoNovavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vaccine...